Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$68.48 - $81.09 $4,588 - $5,433
-67 Reduced 2.02%
3,257 $234,000
Q3 2022

Oct 12, 2022

BUY
$0.13 - $76.84 $8 - $5,148
67 Added 2.06%
3,324 $236,000
Q4 2021

Jan 19, 2022

BUY
$53.63 - $62.52 $174,672 - $203,627
3,257 New
3,257 $203,000
Q3 2021

Oct 08, 2021

SELL
$59.17 - $69.31 $192,716 - $225,742
-3,257 Closed
0 $0
Q4 2020

Jan 19, 2021

SELL
$57.74 - $65.43 $5,889 - $6,673
-102 Reduced 3.04%
3,257 $202,000
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $13,036 - $14,446
-227 Reduced 6.33%
3,359 $203,000
Q2 2020

Jul 09, 2020

BUY
$54.82 - $64.09 $196,584 - $229,826
3,586 New
3,586 $211,000
Q1 2020

Apr 10, 2020

SELL
$46.4 - $67.43 $166,390 - $241,803
-3,586 Closed
0 $0
Q4 2019

Jan 09, 2020

BUY
$49.21 - $64.19 $176,467 - $230,185
3,586 New
3,586 $230,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Traverso Chambers Private Wealth Management, LLC Portfolio

Follow Traverso Chambers Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traverso Chambers Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traverso Chambers Private Wealth Management, LLC with notifications on news.